---
title: 'SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma
  patients: study protocol for an international multicentre prospective cohort study
  (ENCRAM 2201)'
date: '2024-04-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38684246/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240430181515&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'INTRODUCTION: A greater extent of resection of the contrast-enhancing
  (CE) tumour part has been associated with improved outcomes in glioblastoma. Recent
  results suggest that resection of the non-contrast-enhancing (NCE) part might yield
  even better survival outcomes (supramaximal resection, SMR). Therefore, this study
  evaluates the efficacy and safety of SMR with and without mapping techniques in
  high-grade glioma (HGG) patients in terms of survival, functional, neurological,
  cognitive ...'
disable_comments: true
---
INTRODUCTION: A greater extent of resection of the contrast-enhancing (CE) tumour part has been associated with improved outcomes in glioblastoma. Recent results suggest that resection of the non-contrast-enhancing (NCE) part might yield even better survival outcomes (supramaximal resection, SMR). Therefore, this study evaluates the efficacy and safety of SMR with and without mapping techniques in high-grade glioma (HGG) patients in terms of survival, functional, neurological, cognitive ...